Breaking News

Fujifilm Diosynth Biotechnologies Expands UK Site

Enhances cell culture process development labs and creates new biocampus

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fujifilm Diosynth Biotechnologies (FDB), has expanded its UK location through the creation of a new BioCampus. This expansion will be partly supported by the Tess Valley Combined Authority (TVCA) through a  grant funding up to £3.625 million. These funds will help to kick start the first stage of the BioCampus while at the same time enabling  subsequent phases of investment and development planned by FDB. The total cost of the BioCampus project is estimated to be £12.6 million.   The initial pha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters